Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2022

Jun 9, 2022

34491_dirs_2022-06-09_ccf23678-3df1-4751-b85d-943256221dd4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2022-06-07

Reporting Person: Scimeca Dario (General Counsel and Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-06-07 Common Stock M 22727 Acquired 33300 Direct
2022-06-07 Common Stock M 9047 Acquired 42347 Direct
2022-06-08 Common Stock S 9833 $2.06 Disposed 32514 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-06-07 Restricted Stock Units $ M 22727 Disposed Common Stock (22727) Direct
2022-06-07 Restricted Stock Units $ M 9047 Disposed Common Stock (9047) Direct

Footnotes

F1: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022.

F2: Each RSU represents a contingent right to receive one share of the Company's Common Stock.

F3: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

F4: On June 7, 2021 the Reporting person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

F5: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.